Back to results
US 2010/0306866 A1Published application
Adropin deficient mice and uses thereof
OwnerAndrew A. Butlerinventor
Life of this patent
Estimating the term…
Abstract
Mice lacking expression of the Enho gene provide useful tools in the study of the Enho gene and to investigate possible treatments for glucose, lipid and energy metabolism.
Claims50
A transgenic mouse, the genome of which comprises a homozygous disruption of the endogenous Enho gene, wherein said transgenic mouse is characterized by reduced ADROPIN peptide activity.
A transgenic mouse, the genome of which comprises a heterozygous disruption of the endogenous Enho gene, wherein said transgenic mouse is characterized by reduced ADROPIN peptide activity.
Dependencies are inferred from the claim text.